Conditions: Type 2 Diabetes Mellitus
Keywords: Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 497
Healthy volunteers: no

Brief summary:
The purpose of this clinical research study is to learn if BMS-512148 (Dapagliflozin) can help reduce the blood sugar levels in subjects with Type 2 Diabetes who are not well controlled on diet and exercise alone. The safety of this treatment will also be studied

Detailed description:

Arms:
arm 1: Dapagliflozin: 1 mg arm 2: Dapagliflozin: 2.5 mg arm 3: Dapagliflozin: 5 mg arm 4: Placebo: 0 mg

Interventions: intervention 1: Dapagliflozin intervention 2: Placebo
Intervention descriptions: intervention 1: Tablets, Oral, Once Daily, Up to 24 weeks intervention 2: Tablets, Oral, Once Daily, Up to 24 weeks

Protocol document: